Table 2.

Summary of Patients With Serious Adverse Events Requiring Drug Discontinuation in This Study

Patient number	Adverse events		The day of drug discontinuation
Tolvaptan group
Pt. #82	Hypernatremia	Na 147 mEq/L	4th day
Carperitide group
Pt. #3	Worsening heart failure	Worsening pulmonary congestion	5th day
Pt. #28	Hypotension	SBP < 80 mmHg	1st day
Pt. #32	Hypotension	SBP < 80 mmHg	3rd day
Pt. #43	Liver dysfunction	AST 77 IU/L, ALT 179 IU/L	20th day
Pt. #60	Hypotension	SBP < 90 mmHg with general fatigue	2nd day
Pt. #73	Hypotension	SBP < 70 mmHg	2nd day
Pt. #96	Hypotension	SBP < 80 mmHg with dizziness	7th day

SBP, systolic blood pressure; AST, aspartate amino transferase; ALT, alanine transaminase.